Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches
Abstract Cell death is critical in tumor biology. The common cancer therapies can cause cell death and alleviate tumor, while the cancer cells can develop a resistance to cell death and survive from the therapies. Thus, not only observing the alternative mechanisms of tumor cells resistant to cell d...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-03-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02376-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849774796131270656 |
|---|---|
| author | Wenxin Wang Tong Li Kui Wu |
| author_facet | Wenxin Wang Tong Li Kui Wu |
| author_sort | Wenxin Wang |
| collection | DOAJ |
| description | Abstract Cell death is critical in tumor biology. The common cancer therapies can cause cell death and alleviate tumor, while the cancer cells can develop a resistance to cell death and survive from the therapies. Thus, not only observing the alternative mechanisms of tumor cells resistant to cell death, but also understanding the intricate dynamics of cell death processes within the tumor microenvironment (TME), are essential for tailoring effective therapeutic strategies. High-throughput sequencing technologies have revolutionized cancer research by enabling comprehensive molecular profiling. Recent advances in single cell sequencing have unraveled the heterogeneity of TME components, shedding light on their complex interactions. In this review, we explored the interplay between cell death signaling and the TME, summarised the potential drugs inducing cell death in pre-clinical stage, reviewed some studies applying next-generation sequencing technologies in cancer death research, and discussed the future utilization of updated sequencing platforms in screening novel treatment methods targeted cell death. In conclusion, leveraging multi-omics technologies to dissect cell death signaling in the context of the TME holds great promise for advancing cancer research and therapy development. |
| format | Article |
| id | doaj-art-b0bec571dc7d4af1b1b7044db63855e9 |
| institution | DOAJ |
| issn | 2058-7716 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death Discovery |
| spelling | doaj-art-b0bec571dc7d4af1b1b7044db63855e92025-08-20T03:01:37ZengNature Publishing GroupCell Death Discovery2058-77162025-03-0111111710.1038/s41420-025-02376-1Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approachesWenxin Wang0Tong Li1Kui Wu2BGI GenomicsBGI GenomicsBGI GenomicsAbstract Cell death is critical in tumor biology. The common cancer therapies can cause cell death and alleviate tumor, while the cancer cells can develop a resistance to cell death and survive from the therapies. Thus, not only observing the alternative mechanisms of tumor cells resistant to cell death, but also understanding the intricate dynamics of cell death processes within the tumor microenvironment (TME), are essential for tailoring effective therapeutic strategies. High-throughput sequencing technologies have revolutionized cancer research by enabling comprehensive molecular profiling. Recent advances in single cell sequencing have unraveled the heterogeneity of TME components, shedding light on their complex interactions. In this review, we explored the interplay between cell death signaling and the TME, summarised the potential drugs inducing cell death in pre-clinical stage, reviewed some studies applying next-generation sequencing technologies in cancer death research, and discussed the future utilization of updated sequencing platforms in screening novel treatment methods targeted cell death. In conclusion, leveraging multi-omics technologies to dissect cell death signaling in the context of the TME holds great promise for advancing cancer research and therapy development.https://doi.org/10.1038/s41420-025-02376-1 |
| spellingShingle | Wenxin Wang Tong Li Kui Wu Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches Cell Death Discovery |
| title | Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches |
| title_full | Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches |
| title_fullStr | Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches |
| title_full_unstemmed | Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches |
| title_short | Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches |
| title_sort | cell death in tumor microenvironment an insight for exploiting novel therapeutic approaches |
| url | https://doi.org/10.1038/s41420-025-02376-1 |
| work_keys_str_mv | AT wenxinwang celldeathintumormicroenvironmentaninsightforexploitingnoveltherapeuticapproaches AT tongli celldeathintumormicroenvironmentaninsightforexploitingnoveltherapeuticapproaches AT kuiwu celldeathintumormicroenvironmentaninsightforexploitingnoveltherapeuticapproaches |